Skip to main content

Frequently Asked Questions (FAQ): COVID-19 Vaccine Distribution Considerations for the Disability Community

AUCD (Association of University Centers on Disabilities) addresses concerns on the COVID-19 vaccine.

This project is sponsored in part by UCEDD Resource Center and National Center on Disability in Public Health, this paper provides information regarding:

  • Pre-Distribution considerations
  • Distribution guidance
  • Considerations for state and local disability leaders
  • AUCD Network Vaccine Tools and Resources

Click here to download this Frequently Asked Questions paper

Questions answered in this paper:

  • I. What is the federal approval process for a COVID-19 vaccine?
  • II. What is Operation Warp Speed and how does it impact the federal approval process for a COVID-19 vaccine?
  • III. What current vaccine developments are under way?
  • IV. I know a COVID-19 vaccine has not yet been approved for use, but has manufacturing started?
  • V. Has AUCD provided any guidance for COVID-19 vaccine distribution to federal and/or state governments?
  • VI. Have other organizations in the disability community provided any guidance for COVID-19 vaccine distribution to federal and/or state governments?
  • VII. What guidance has the federal government provided for COVID-19 vaccine distribution?
  • VIII. What guidance has my state provided for COVID-19 vaccine distribution?
  • IX. Where do I find my state’s plan?
  • X. My state has county and local health departments. Do they have separate plans?
  • XI. How will the vaccine be distributed at the local level?
  • XII. How can the AUCD network and your AUCD network center be poised to provide guidance to both the disability community and to state and local governments?
  • XIII. What should I be looking for in my review of the state COVID Vaccine plan?
  • XIV. After I have reviewed my state or local plan, how should I share my feedback and with whom?